Reference : Tomographie a emission de positons au 18FDG et adenocarcinome pancreatique
Scientific journals : Article
Human health sciences : Radiology, nuclear medicine & imaging
Human health sciences : Oncology
http://hdl.handle.net/2268/18937
Tomographie a emission de positons au 18FDG et adenocarcinome pancreatique
French
[en] 18fdg-Pet Imaging of Pancreatic Adenocarcinoma
Daenen, Frédéric [Centre Hospitalier Universitaire de Liège - CHU > > Médecine nucléaire >]
Hustinx, Roland mailto [Université de Liège - ULg > Département des sciences cliniques > Médecine nucléaire]
Belhocine, Tarik [> > > >]
Focan, C. [> > > >]
Honore, Pierre mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
Rigo, Pierre mailto [Université de Liège - ULg > Département des sciences de la motricité > Pathologie générale et médecine nucléaire >]
Feb-2000
Revue Médicale de Liège
55
2
89-94
Yes (verified by ORBi)
National
0370-629X
[en] Positron emission tomography ; FDG ; Pancreatic carcinoma
[fr] Oncology
[en] FDG-PET imaging non invasively studies the glucose metabolism which is usually increased in malignant lesions. We evaluated the clinical performance of PET for detecting pancreatic cancer and its recurrence. In our series of 24 studies, PET appears to complement other imaging modalities. As compared to CT, in particular, it demonstrated fewer false positive results in the pancreas and it was also more sensitive. Moreover, whole-body FDG-PET allows for the entire staging of the disease.
http://hdl.handle.net/2268/18937

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Daenen F et al, Rev Med Liege 2000.pdfPublisher postprint714.33 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.